Approved Symbol |
Approved Name |
Source |
Evidence[PMID] |
APLP2 |
amyloid beta (A4) precursor-like protein 2 |
Mapped by significant region |
IPI[16193067]
|
VIL1 |
villin 1 |
Mapped by significant region |
IPI[17606613]
|
P2RX6 |
purinergic receptor P2X, ligand-gated ion channel, 6 |
Mapped by CNV |
IPI[15313628]
|
ZBTB16 |
zinc finger and BTB domain containing 16 |
Mapped by significant region |
IPI[9294197]
|
PRKAB2 |
protein kinase, AMP-activated, beta 2 non-catalytic subunit |
Mapped by CNV |
|
GRIN3A |
glutamate receptor, ionotropic, N-methyl-D-aspartate 3A |
Mapped by significant region |
IPI[17997397]
|
STAC3 |
SH3 and cysteine rich domain 3 |
Mapped by CNV |
IPI[16189514]
|
SQSTM1 |
sequestosome 1 |
Mapped by CNV |
|
ALAD |
aminolevulinate dehydratase |
Mapped by significant region |
IPI[11032836]
|
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
Mapped by CNV |
IPI[16189514]
|
HOOK3 |
hook homolog 3 (Drosophila) |
Mapped by PBA pathway |
IPI[18799622]
|
MLL |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila) |
Mapped by significant region |
IPI[11313484]
|
THG1L |
tRNA-histidine guanylyltransferase 1-like (S. cerevisiae) |
Mapped by significant region |
|
MAP1S |
microtubule-associated protein 1S |
Mapped by PBA pathway |
|
PLN |
phospholamban |
Mapped by significant region |
|
SYT9 |
synaptotagmin IX |
Mapped by CNV |
|
PYCRL |
pyrroline-5-carboxylate reductase-like |
Mapped by LD-proxy |
|
RIPK3 |
receptor-interacting serine-threonine kinase 3 |
Mapped by significant region |
|
PRKD1 |
protein kinase D1 |
Mapped by significant region |
IPI[19135240]
|
NDE1 |
nudE nuclear distribution gene E homolog 1 (A. nidulans) |
Mapped by CNV; Mapped by significant region |
|
KCNRG |
potassium channel regulator |
Mapped by LD-proxy |
IPI[19447967]
|
GPSM2 |
G-protein signaling modulator 2 |
Mapped by CNV |
IPI[15537540]
|
SKP2 |
S-phase kinase-associated protein 2 (p45) |
Mapped by significant region |
|
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
Mapped by CNV; Mapped by significant region |
|
ATL3 |
atlastin GTPase 3 |
Mapped by significant region |
IDA[18270207]
|
PRPF19 |
PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae) |
Mapped by significant region |
IPI[16332694]
|
KCTD13 |
potassium channel tetramerisation domain containing 13 |
Mapped by CNV |
|
PTS |
6-pyruvoyltetrahydropterin synthase |
Mapped by significant region |
IPI[16189514]
|
RILPL2 |
Rab interacting lysosomal protein-like 2 |
Mapped by CNV |
IPI[16189514]
|
TSSK2 |
testis-specific serine kinase 2 |
Mapped by CNV |
IPI[15044604]
|
MAP3K11 |
mitogen-activated protein kinase kinase kinase 11 |
Mapped by significant region |
IPI[9829970]
|
CLDN5 |
claudin 5 |
Mapped by CNV |
|
CTSC |
cathepsin C |
Mapped by significant region |
|
TNN |
tenascin N |
Mapped by significant region |
|
CBX3 |
chromobox homolog 3 |
Mapped by CNV; Mapped by significant region |
|
C1QTNF3 |
C1q and tumor necrosis factor related protein 3 |
Mapped by significant region |
|
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
Mapped by significant region |
IPI[7527811]
|
SSSCA1 |
Sjogren syndrome/scleroderma autoantigen 1 |
Mapped by significant region |
|
ACY3 |
aspartoacylase (aminocyclase) 3 |
Mapped by significant region |
|
USP2 |
ubiquitin specific peptidase 2 |
Mapped by significant region |
|
GLUL |
glutamate-ammonia ligase |
Mapped by significant region |
|
ERBB2 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
Mapped by LD-proxy |
|
APOA1 |
apolipoprotein A-I |
Mapped by significant region |
IPI[8049247]
|
PON2 |
paraoxonase 2 |
Mapped by PBA pathway |
IDA[15772423]
|
TRIM5 |
tripartite motif containing 5 |
Mapped by CNV |
|
TPCN2 |
two pore segment channel 2 |
Mapped by CNV; Mapped by significant region |
|
FADD |
Fas (TNFRSF6)-associated via death domain |
Mapped by significant region |
IPI[8681376]
|
ALDOB |
aldolase B, fructose-bisphosphate |
Mapped by significant region |
IPI[10625657]
|
PAK1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
Mapped by significant region |
|
EED |
embryonic ectoderm development |
Mapped by significant region |
IPI[11124122]
|
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
Mapped by LD-proxy; Mapped by significant region |
|
AMOTL1 |
angiomotin like 1 |
Mapped by significant region |
IDA[16019084]
|
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
Mapped by significant region |
IDA[9437432]; IPI[10498867]
|
ALDOA |
aldolase A, fructose-bisphosphate |
Mapped by CNV |
TAS[14766013]
|
TTK |
TTK protein kinase |
Mapped by PBA pathway |
|
C1QTNF2 |
C1q and tumor necrosis factor related protein 2 |
Mapped by significant region |
|
RYR2 |
ryanodine receptor 2 (cardiac) |
Mapped by CNV; Mapped by PBA pathway |
IPI[10830164]
|
SHMT2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
Mapped by CNV |
|
TPD52L1 |
tumor protein D52-like 1 |
Mapped by significant region |
IPI[9484778]
|
PRC1 |
protein regulator of cytokinesis 1 |
Mapped by PBA pathway |
|
HNRNPC |
heterogeneous nuclear ribonucleoprotein C (C1/C2) |
Mapped by PBA pathway |
IPI[16189514]
|